Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹5,545 Cr
up ₹153 Cr vs Jul 2023
- Stocks held
- 30
- up 1 vs Jul 2023
- Top 10 weight
- 57.9%
- of the portfolio in its ten largest
- Cash & debt
- 3.2%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 15
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In August 2023 it disclosed 30 stocks worth ₹5,545 Cr, up ₹153 Cr from Jul 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.1%), Lupin Limited (7.5%), Cipla Limited (6.8%); the ten largest together made up 57.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.8% of its equity. Cash and debt stood at 3.2%. Compared with Jul 2023 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
79%
Top-10 weight is higher than 79% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
47%
Holds more cash than 47% of peers
Holdings in August 2023
Download CSVEvery line the fund disclosed, with the change against Jul 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.14%
- Δ weight
- down 0.76 pts
- Value
- ₹729 Cr
- Δ value
- down ₹20.8 Cr
- Status
- Trimmed
- Weight
- 7.53%
- Δ weight
- up 0.21 pts
- Value
- ₹418 Cr
- Δ value
- up ₹23 Cr
- Status
- Added
- Weight
- 6.80%
- Δ weight
- up 0.27 pts
- Value
- ₹377 Cr
- Δ value
- up ₹24.8 Cr
- Status
- Added
- Weight
- 5.56%
- Δ weight
- down 0.19 pts
- Value
- ₹308 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 4.71%
- Δ weight
- up 1.80 pts
- Value
- ₹261 Cr
- Δ value
- up ₹104 Cr
- Status
- Added
- Weight
- 4.54%
- Δ weight
- down 0.25 pts
- Value
- ₹252 Cr
- Δ value
- down ₹6.5 Cr
- Status
- Trimmed
- Weight
- 4.50%
- Δ weight
- up 1.09 pts
- Value
- ₹250 Cr
- Δ value
- up ₹65.8 Cr
- Status
- Added
- Weight
- 3.74%
- Δ weight
- down 0.83 pts
- Value
- ₹208 Cr
- Δ value
- down ₹39.2 Cr
- Status
- Trimmed
- Weight
- 3.74%
- Δ weight
- up 0.22 pts
- Value
- ₹207 Cr
- Δ value
- up ₹17.5 Cr
- Status
- Added
- Weight
- 3.61%
- Δ weight
- down 0.14 pts
- Value
- ₹200 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 3.59%
- Δ weight
- down 0.38 pts
- Value
- ₹199 Cr
- Δ value
- down ₹14.9 Cr
- Status
- Trimmed
- Weight
- 3.56%
- Δ weight
- up <0.01 pts
- Value
- ₹197 Cr
- Δ value
- up ₹5.5 Cr
- Status
- Added
- Weight
- 3.42%
- Δ weight
- up 0.39 pts
- Value
- ₹190 Cr
- Δ value
- up ₹26.1 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 3.22%
- Δ weight
- up 0.27 pts
- Value
- ₹178 Cr
- Δ value
- up ₹19.5 Cr
- Status
- Added
- Weight
- 3.19%
- Δ weight
- up 0.02 pts
- Value
- ₹177 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 3.18%
- Δ weight
- down 0.23 pts
- Value
- ₹177 Cr
- Δ value
- down ₹7.3 Cr
- Status
- Trimmed
- Weight
- 3.02%
- Δ weight
- down 0.05 pts
- Value
- ₹168 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 3.02%
- Δ weight
- down 0.03 pts
- Value
- ₹167 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 2.64%
- Δ weight
- down 0.33 pts
- Value
- ₹147 Cr
- Δ value
- down ₹13.5 Cr
- Status
- Trimmed
- Weight
- 2.09%
- Δ weight
- down 1.23 pts
- Value
- ₹116 Cr
- Δ value
- down ₹63.4 Cr
- Status
- Trimmed
- Weight
- 2.02%
- Δ weight
- down 0.15 pts
- Value
- ₹112 Cr
- Δ value
- down ₹5.1 Cr
- Status
- Trimmed
- Weight
- 2.00%
- Δ weight
- down 0.24 pts
- Value
- ₹111 Cr
- Δ value
- down ₹9.7 Cr
- Status
- Trimmed
- Weight
- 1.71%
- Δ weight
- down 0.23 pts
- Value
- ₹95 Cr
- Δ value
- down ₹9.9 Cr
- Status
- Trimmed
- Weight
- 1.12%
- Δ weight
- down 0.06 pts
- Value
- ₹62.1 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 1.05%
- Δ weight
- down 0.03 pts
- Value
- ₹58.2 Cr
- Δ value
- up ₹2 L
- Status
- Held
- Weight
- 1.00%
- Δ weight
- down 0.07 pts
- Value
- ₹55.2 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 0.88%
- Δ weight
- up 0.88 pts
- Value
- ₹48.8 Cr
- Δ value
- up ₹48.8 Cr
- Status
- New
- Weight
- 0.47%
- Δ weight
- up 0.08 pts
- Value
- ₹25.8 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 0.46%
- Δ weight
- down <0.01 pts
- Value
- ₹25.7 Cr
- Δ value
- up ₹60 L
- Status
- Added
- Weight
- 0.25%
- Δ weight
- up 0.01 pts
- Value
- ₹14.1 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.21%
- Δ weight
- down 0.04 pts
- Value
- ₹11.4 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
What changed, Jul 2023 to Aug 2023
New New positions (1)
- Concord Biotech Limited0.9% · ₹48.8 Cr
Exited Exited (0)
None.
Added Biggest additions
- Gland Pharma Limitedup ₹104 Cr (+1.80% pts)
- MedPlus Health Services Limitedup ₹65.8 Cr (+1.09% pts)
- Vijaya Diagnostic Centre Limitedup ₹26.1 Cr (+0.39% pts)
- Cipla Limitedup ₹24.8 Cr (+0.27% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2023, the weight rose most in Retailing (+1.1 pts) and Pharmaceuticals & Biotechnology (+0.4 pts), and fell most in Healthcare Services (−1.5 pts).
- Retailing3.5% → 4.7%+1.1 pts
- Pharmaceuticals & Biotechnology77.3% → 77.8%+0.4 pts
- Healthcare Services17.8% → 16.3%−1.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2020 | Aug 2022 | Feb 2023 | May 2023 | Jul 2023 | Aug 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.7% | 80.6% | 76.8% | 76.3% | 77.3% | 77.8% |
| Healthcare Services | 19.2% | 17.4% | 19.7% | 18.5% | 17.8% | 16.3% |
| Retailing | — | — | 1.6% | 3.5% | 3.5% | 4.7% |
| Pharmaceuticals | 2.1% | 1.4% | 1.6% | 1.4% | 1.1% | 1.1% |
| Healthcare Equipment & Supplies | — | 0.6% | 0.3% | 0.3% | 0.3% | 0.2% |
Allocation in Aug 2023change vs Jul 2023
- Pharmaceuticals & Biotechnology (20)77.8%▲ 0.4 pts
- Healthcare Services (7)16.3%▼ 1.5 pts
- Retailing (1)4.7%▲ 1.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Aug 2023
3.2%
▲ 0.3 pts vs Jul 2023
- Cash alone
- 3.3%
- cash and net receivables
- A year earlier
- 0.3%
- Aug 2022 · now ▲ 2.9 pts
- Last 12 months
- 0.4% – 3.2%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.